I have searched for highly profitable companies that pay very rich dividends and that are in a short-term uptrend and in a mid-term uptrend. Stocks in an uptrend are performing well and are in a buying mode. Those stocks would also have to show a very low trailing and forward P/E ratio.
I have elaborated a screening method, which shows stock candidates following these lines. Nonetheless, the screening method should only serve as a basis for further research. All the data for this article were taken from Yahoo Finance and finviz.com. The screen's formula requires all stocks to comply with all following demands:
The forward dividend yield is greater than 3.90%. The payout ratio is less than 85%. Trailing P/E is less than 12. Forward P/E is less than 12. The stock price is above the 20-day simple moving average (short-term uptrend). The stock price is above the 50-day simple moving average (mid-term uptrend).After running this screen on August 16, 2013, before the market open, I discovered the following four stocks:
Hot Japanese Stocks To Invest In Right Now: Unifi Inc (UFI)
Unifi, Inc., sells fibers made from polyester and nylon filament to other yarn manufacturers, knitters and weavers that produce fabric for the apparel, hosiery, sock, home furnishing, automotive upholstery, industrial and other markets. The Company's polyester yarn products include polyester polymer beads (Chip), partially oriented yarn (POY), textured, solution and package dyed, twisted and beamed yarns. The Company's nylon products include textured, solution dyed and covered spandex products. The Company operates in three segments: Polyester segment, Nylon segment and International segment. In December 2013, Unifi Inc acquired American Drawtech Co Inc.
The Polyester segment manufactures Chip, POY, textured, dyed, twisted and beamed yarns, virgin and recycled, with sales primarily to other yarn manufacturers, knitters and weavers that produce yarn and/or fabric for the apparel, hosiery, automotive upholstery, home furnishing, industrial and other end-use markets. The Polyester segment consists of manufacturing operations in the United States and El Salvador. The Nylon segment manufactures textured nylon and covered spandex yarns with sales to knitters and weavers that produce fabric for the apparel, hosiery, sock and other end-use markets. The Nylon segment consists of manufacturing operations in the United States and Colombia. The International segment's products primarily include textured polyester and range of resale yarns. The International segment sells its yarns to knitters and weavers that produce fabric for the apparel, automotive upholstery, home furnishing, industrial and other end-use markets primarily in the South American and Asian regions.
The Company manufactures polyester related products in the United States, El Salvador and Brazil and nylon yarns in the United States and Colombia for a range of end-uses. The Company processes and sells POY, as well as high-volume commodity, specialty, and PVA yarns, domestically and internationally, with PVA yarns making up! approximately 18% consolidated sales for the fiscal year ended June 24, 2012.
The Company competes with O'Mara, Inc., NanYa Plastics Corp., AKRA, S.A. de C.V., C S Central America S.A. de C.V., Avanti Industria Comercio Importacao e Exportacao Ltda., Polyenka Ltda., Sapona Manufacturing Company, Inc., McMichael Mills, Inc. and Worldtex, Inc.
Advisors' Opinion:- [By Javier Hasse, Insider Monkey]
Once again, MedAssets trades below its industry average valuation of 62.1 x P/E, at 49.3x. Its valuation becomes even more attractive when one looks at the company麓s P/B ratio (2.8x vs. an industry average of 15.6x) and P/S ratio (2.0x vs. 4.7x). However, below average margins, returns and growth projections are three major sources of concern.
Unifi (UFI)Finally, there’s Unifi (UFI), a $421 million market cap diversified producer and processor of multi-filament polyester and nylon yarns.
Top Performing Stocks To Buy Right Now: Asta Funding Inc.(ASFI)
Asta Funding, Inc., together with its subsidiaries, engages in purchasing, managing, and servicing distressed consumer receivables in the United States. Its principal portfolio includes charged-off receivables consisting of accounts that have been written-off by the originators and might have been previously serviced by collection agencies; semi-performing receivables, including accounts where the debtor is currently making partial or irregular monthly payments, but the accounts might have been written-off by the originators; performing receivables comprising accounts where the debtor is making regular monthly payments that might or might not have been delinquent in the past; and distressed consumer receivables, such as the unpaid debts of individuals to banks, finance companies, and other credit and service providers. The company?s distressed consumer receivables consist of MasterCard, Visa, and other credit card accounts, which were charged-off by the issuers or provide rs for non-payment. Asta Funding, Inc. was founded in 1994 and is based in Englewood Cliffs, New Jersey.
Advisors' Opinion:- [By John Udovich]
Small cap debt collection stocks like�Asta Funding, Inc (NASDAQ: ASFI), Encore Capital Group, Inc (NASDAQ: ECPG) and Portfolio Recovery Associates, Inc (NASDAQ: PRAA) could be the latest target of a government shakedown or crackdown as the Consumer Financial Protection Bureau said this week that�before it formally proposes any rules for debt collection, it wants to hear how collectors verify borrowers' information and communicate with consumers. In other words, debt collectors could be restricted from using text messages, social media or other Internet-based tools in their pursuit to collect debts. With about one in 10 Americans coming out of the financial crisis with some debt in collection, investing in small cap�debt collection stocks has been profitable for investors. However, there is no timeline for when any new rules might be released for review or come into effect.
- [By Tim Melvin]
There a lot of moving parts to Asta Funding (ASFI), but there appears to be a great deal of value that isn�� reflected in the current stock price. ASFI stock is trading at less than 65% of book value, but several of its debt collection assets are carried at zero cost basis and yet may have substantial value. The balance sheet is strong with more than $90 million in cash. ASFI has been moving into other businesses including disability claims to increase its growth opportunities over the next few years. It�� a fairly complex business, but it is very cheap — and the first sign of good news could send the shares a lot higher.
Top Performing Stocks To Buy Right Now: Bellway PLC (BWY)
Bellway p.l.c. is a United Kingdom-based holding company, owning subsidiary undertakings, which is engaged principally in housebuilding in the United Kingdom. The Company�� subsidiaries include Bellway Homes Limited, Bellway Properties Limited, Bellway (Services) Limited, Litrose Investments Limited, Bellway Financial Services Limited, Bellway Housing Trust Limited and The Victoria Dock Company Limited. Advisors' Opinion:- [By Sofia Horta e Costa]
Bellway Plc (BWY) added 1.4 percent after the homebuilder said reservations in the past four months rose 31 percent as buyers had greater access to mortgages. Elan (ELN) Corp. jumped to a 10-month high in Dublin after Royalty Pharma increased its offer for the Irish drugmaker to as much as $6.7 billion. BT Group increased 3.7 percent as Barclays Plc recommended investors buy shares of the U.K.�� largest fixed-line company.
Top Performing Stocks To Buy Right Now: STEC Inc.(STEC)
STEC, Inc. designs, manufactures, and markets enterprise-class flash solid-state drives (SSDs) for use in high-performance storage and server systems. Its solid-state drive products include ZeusIOPS SSDs, which provide enterprise-class data storage solutions; and MACH-class SSDs that are small form factor storage solutions for mission-critical systems in various industries. The company?s flash cards and flash module products comprise ATA PC Cards for equipment requiring standard form factors and moderate capacities, such as data recorders, avionics systems, and telecommunication applications; CompactFlash products, which provide interoperability with systems based on the PC Card ATA standard by using a passive adapter; flash modules; secure digital memory cards; USB flash drives; and single chip drives. It also offers dynamic random access memory (DRAM) products, which include dual in-line memory modules (DIMMs), small-outline DIMMs, mini-registered DIMMs, very low profile registered DIMMs, and fully-buffered DIMMs for computing, communications, and industrial applications. In addition, the company provides integrated circuit tower stacked components for thin small outline package and ball grid array semiconductor packages for use on memory modules and within high capacity flash products; DRAM modules with stacked components for use primarily in high-performance servers, workstations, switches and routers, and other custom systems; and flash products with stacked components. It sells its products through direct sales force and original equipment manufacturer distributors in the United States and internationally. STEC, Inc. was founded in 1990 and is headquartered in Santa Ana, California.
Advisors' Opinion:- [By Tim Brugger]
HGST, a wholly owned subsidiary of Western Digital (NASDAQ: WDC ) , has entered into an agreement whereby HGST will acquire a 100% ownership stake in sTec (NASDAQ: STEC ) in an all-cash transaction valued at $340 million, equal to $6.85 a share, the companies announced today.
Top Performing Stocks To Buy Right Now: VIVUS Inc (VVUS)
VIVUS, Inc., incorporated on May 16, 1996, is a biopharmaceutical company. It commercializes and develops therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. The Company's drug, Qsymia (phentermine and topiramate extended-release) was approved by the the United States Food and Drug Administration (FDA) for the treatment of obesity as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 or greater (obese), or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus or high cholesterol (dyslipidemia). Qsymia incorporates low doses of active ingredients from two previously approved drugs, phentermine and topiramate. It has completed Phase 2 clinical studies for Qsymia for the treatment of sleeps apnea and Qsymia for the treatment of type 2 diabetes. Its drug also includes STENDRA, or avanafil.
Qsymia for the treatment of obesity was approved as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial BMI of 30 or greater (obese), or 27 or greater (overweight) in the presence of at least one weight-related comorbidity, such as hypertension, type 2 diabetes mellitus or high cholesterol (dyslipidemia). Qsymia incorporates low doses of active ingredients from two previously approved drugs, phentermine and topiramate.
The Company initially launched Qsymia for distribution to eligible patients through the home delivery networks of two certified pharmacies, CVS Pharmacy and Walgreens. Since then, it has expanded the distribution of Qsymia to include the home delivery networks of Express Scripts, Wal-Mart Pharmacy and, for its members only, Kaiser Permanente. Clinical studies of topiramate, a component of Qsymia, in type 2 diabetics resulted in a clinically reduction of hemoglobin A1c (HbA1c). The! Company's drug, STENDRA (avanafil), is an oral PDE5 inhibitor the Company has licensed from Mitsubishi Tanabe Pharma Corporation (MTPC).
Advisors' Opinion:- [By Keith Speights]
Pharmaceutical companies are getting into the act. For example, Vivus (NASDAQ: VVUS ) recently introduced an app for iPhones (and Android phones) that complements its weight-loss drug. The app allows patients to record what they eat and track their weight plus receive regular information updates.
- [By Maxx Chatsko]
BigBrain could also lead to future obesity treatments. Several studies have shown that deep brain stimulation, via surgically implanted electrodes, can result in weight-loss in lab animals. It works by disrupting the brain's habit circuitry. Similar procedures have actually been performed on humans with alcoholism to alter the neurological pathways responsible to addiction. You may feel more comfortable taking an oral therapy, such as Belviq from Arena Pharmaceuticals (NASDAQ: ARNA ) or Qsymia from VIVUS (NASDAQ: VVUS ) , than having your cranium cracked open. That is understandable. Both Belviq and Qsymia work to chemically subdue appetite pathways, such as serotonin 2C receptors. Implanted electrodes would work in a similar fashion, albeit in a more permanent way. Will Arena or VIVUS be marketing deep brain stimulation therapy for obesity in 20 years? Perhaps, but they need to figure out how to successfully market their oral therapies first.
- [By WALLSTCHEATSHEET]
Vivus is a biopharmaceutical company that is attacking issues negatively affecting many Americans. The stock has not done too well lately but may be currently stabilizing from a recent rise in selling. Earnings have been decreasing over the last four quarters, which has not really made investors too happy. Relative to its peers and sector, Vivus has trailed significantly in year-to-date performance. STAY AWAY from Vivus’s stock for now.
Top Performing Stocks To Buy Right Now: Zhongpin Inc.(HOGS)
Zhongpin Inc. engages in the processing and distribution of meat and food products primarily in the People?s Republic of China. The company provides pork and pork products, such as chilled pork, frozen pork, hog by-products and variety meats, and prepared meats; and vegetable and fruit products, including asparagus, sweet corn, broccoli, mushrooms, lima beans, strawberries, and capsicums. It sells its products fast food companies, processing factories, school cafeterias, factory canteens, hotels, army bases, and government departments, as well as directly to retail outlets, including supermarkets. The company also exports its products to Europe, Hong Kong, and other countries in Asia. As of December 31, 2010, it operated 157 showcase stores, 1,072 branded stores, and 2,097 supermarket counter locations. The company is headquartered in Changge City, the People?s Republic of China.
Advisors' Opinion:- [By Dan Caplinger]
Obviously, the big news for Smithfield during the quarter came from Shuanghui International's offer to buy out the company for $34 per share. The $4.7 billion offer has raised some nationalistic concerns, as the Committee on Foreign Investment in the U.S. will have to approve the merger, but Smithfield CEO Larry Pope said last month when the deal was announced that it believes the deal won't have an effect on the company's operations. In fact, the combination of China's largest meat processor and the world's biggest pork producer could produce a formidable opponent to industry rivals. In particular, Chinese pork producer Zhongpin (NASDAQ: HOGS ) will inevitably find itself under pressure if the deal goes through, as Shuanghui puts itself in a stronger competitive position in the industry.
No comments:
Post a Comment